
- /
- Supported exchanges
- / US
- / TOIIW.NASDAQ
The Oncology Institute Inc (TOIIW NASDAQ) stock market data APIs
The Oncology Institute Inc Financial Data Overview
The Oncology Institute, Inc., an oncology company, provides various medical oncology services in the United States. The company operates through three segments: Dispensary, Patient Services, and Clinical Trials & Other. It offers physician services, in-house infusion and dispensary, clinical trial, radiation, outpatient blood product transfusion, and patient support services, as well as educational seminars, support groups, counseling services, and 24/7 patient assistance services. The company also provides and manages clinical trials, palliative care programs, stem cell transplants services, other care delivery models associated with non-community-based academic, and tertiary care settings; and conducts clinical trials for a range of pharmaceutical, and medical device companies. It serves adult and senior cancer patients. The Oncology Institute, Inc. was founded in 2007 and is headquartered in Cerritos, California.
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Or get access to advanced financial data starting only $19.99
Get The Oncology Institute Inc data using free add-ons & libraries
Get The Oncology Institute Inc Fundamental Data
The Oncology Institute Inc Fundamental data includes:
- Net Revenue: 424 M
- EBITDA: -40 035 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
End-of-day & Earnings data
What’s included:
- Latest Release: NaN
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
The Oncology Institute Inc News

The Oncology Institute anticipates Q4 adjusted EBITDA positivity as pharmacy revenue grows 41%
Earnings Call Insights: The Oncology Institute, Inc. (TOI) (TOI) Q2 2025 MANAGEMENT VIEW * CEO Daniel Virnich reported continued "strong momentum" into the second quarter, highlighting year-over-y...


The Oncology Institute Names Kristin England as Chief Administrative Officer
Toi Management, LLC CERRITOS, Calif., July 14, 2025 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI) (“TOI”), one of the largest value-based oncology groups in the United States, an...

The Oncology Institute Becomes Exclusive Oncology Provider for 80,000+ SilverSummit Healthplan Medicaid Members
The Oncology Institute Inc. (NASDAQ:TOI) is one of the best-performing NASDAQ stocks according to analysts. On June 30, the Oncology Institute announced a partnership with SilverSummit Healthplan. Eff...

Oncology Institute And 2 Other Promising Penny Stocks To Watch
Over the last 7 days, the United States market has risen by 2.9%, and over the past year, it is up 12%, reflecting a period of growth and optimism. In such a climate, identifying stocks with solid fin...
Or get access to advanced financial data starting only $19.99
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.